Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -11.54% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 82.53% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 43.08% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 28.57% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -26.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -24.77% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 33.30% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 81.16% |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | -41.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41.72% |
| Mar 31, 2026 | -38.13% |
| Dec 31, 2025 | -534.93% |
| Sep 30, 2025 | -24.05% |
| Jun 30, 2025 | -24.07% |
| Mar 31, 2025 | -26.44% |
| Dec 31, 2024 | -38.13% |
| Sep 30, 2024 | -6.60% |
| Jun 30, 2024 | -3.72% |
| Mar 31, 2024 | 41.29% |
| Dec 31, 2023 | -34.50% |
| Sep 30, 2023 | 11.77% |
| Jun 30, 2023 | 0.72% |
| Mar 31, 2023 | -7.82% |
| Dec 31, 2022 | 4.02% |
| Sep 30, 2022 | -41.79% |
| Jun 30, 2022 | -107.24% |
| Mar 31, 2022 | -96.08% |
| Dec 31, 2021 | 29.18% |
| Sep 30, 2021 | 30.41% |